Novavax Vaccine Study For Children

covid vaccine for children

We are happy to announce that the Novavax vaccine is being reviewed by the FDA for Emergency Use Authorization in adults, and they are opening a research study to children ages 12 to 17. We expect children ages 6 to 11 will be enrolling shortly. If you or someone you know is interested in enrolling their child in the study, … Read More

Pfizer COVID-19 Vaccine FAQ


The following article relates to the Pfizer COVID Vaccine Protocol#C4591001: All participants who courageously volunteered to help make a difference during this pandemic have the option to receive the investigational vaccine while continuing to be part of the clinical trial. The Vaccine Transition Option The Vaccine Transition Option is a voluntary process that offers all participants 16 years and older … Read More